{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:56:58Z","timestamp":1791619018584,"version":"4.3.4"},"reference-count":78,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatric Clinics of North America"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.psc.2024.02.005","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T13:58:48Z","timestamp":1710511128000},"page":"355-365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cognitive-Behavioral Therapy Enhancement Strategies"],"prefix":"10.1016","volume":"47","author":[{"given":"David F.","family":"Tolin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla A.","family":"Lord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Knowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.psc.2024.02.005_bib1","doi-asserted-by":"crossref","first-page":"621","DOI":"10.4088\/JCP.v69n0415","article-title":"Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials","volume":"69","author":"Hofmann","year":"2008","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"7","key":"10.1016\/j.psc.2024.02.005_bib2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1177\/070674371305800702","article-title":"A\u00a0meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments","volume":"58","author":"Cuijpers","year":"2013","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.psc.2024.02.005_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cpr.2015.08.004","article-title":"Response rates for CBT for anxiety disorders: Need for standardized criteria","volume":"42","author":"Loerinc","year":"2015","journal-title":"Clin Psychol Rev"},{"issue":"3","key":"10.1016\/j.psc.2024.02.005_bib4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/acps.13335","article-title":"The effects of psychotherapies for depression on response, remission, reliable change, and deterioration: A meta-analysis","volume":"144","author":"Cuijpers","year":"2021","journal-title":"Acta Psychiatr Scand"},{"issue":"7509","key":"10.1016\/j.psc.2024.02.005_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/bmj.331.7509.155","article-title":"Efficacy of antidepressants in adults","volume":"331","author":"Moncrieff","year":"2005","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.psc.2024.02.005_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/YIC.0000000000000078","article-title":"Efficacy of treatments for anxiety disorders: a meta-analysis","volume":"30","author":"Bandelow","year":"2015","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.psc.2024.02.005_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.2009.1943","article-title":"Antidepressant drug effects and depression severity: a patient-level meta-analysis","volume":"303","author":"Fournier","year":"2010","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.psc.2024.02.005_bib8","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.psc.2017.08.007","article-title":"Can cognitive behavioral therapy for anxiety and depression be improved with pharmacotherapy? A meta-analysis","volume":"40","author":"Tolin","year":"2017","journal-title":"Psychiatr Clin North Am"},{"issue":"19","key":"10.1016\/j.psc.2024.02.005_bib9","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1001\/jama.283.19.2529","article-title":"Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial","volume":"283","author":"Barlow","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.psc.2024.02.005_bib10","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1192\/bjp.162.6.776","article-title":"Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto","volume":"162","author":"Marks","year":"1993","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.psc.2024.02.005_bib11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.npp.1301555","article-title":"Neural mechanisms of extinction learning and retrieval","volume":"33","author":"Quirk","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.psc.2024.02.005_bib12","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1523\/JNEUROSCI.12-03-00854.1992","article-title":"Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala","volume":"12","author":"Falls","year":"1992","journal-title":"J\u00a0Neurosci"},{"issue":"6","key":"10.1016\/j.psc.2024.02.005_bib13","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1523\/JNEUROSCI.22-06-02343.2002","article-title":"Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats","volume":"22","author":"Walker","year":"2002","journal-title":"J\u00a0Neurosci"},{"issue":"6","key":"10.1016\/j.psc.2024.02.005_bib14","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jpsychires.2006.05.006","article-title":"A\u00a0randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear","volume":"41","author":"Guastella","year":"2007","journal-title":"J\u00a0Psychiatr Res"},{"issue":"11","key":"10.1016\/j.psc.2024.02.005_bib15","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/archpsyc.61.11.1136","article-title":"Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear","volume":"61","author":"Ressler","year":"2004","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"10.1016\/j.psc.2024.02.005_bib16","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/da.22531","article-title":"Randomized trial of d-cycloserine enhancement of cognitive-behavioral therapy for panic disorder","volume":"33","author":"Otto","year":"2016","journal-title":"Depress Anxiety"},{"issue":"3","key":"10.1016\/j.psc.2024.02.005_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1176\/appi.ajp.2007.07050776","article-title":"Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder","volume":"165","author":"Wilhelm","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"7","key":"10.1016\/j.psc.2024.02.005_bib18","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/jamapsychiatry.2015.0546","article-title":"D-cycloserine vs placebo as adjunct to cognitive behavioral therapy for obsessive-compulsive disorder and interaction with antidepressants: A randomized clinical trial","volume":"72","author":"Andersson","year":"2015","journal-title":"JAMA Psychiatr"},{"issue":"3","key":"10.1016\/j.psc.2024.02.005_bib19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/archpsyc.63.3.298","article-title":"Augmentation of exposure therapy with D-cycloserine for social anxiety disorder","volume":"63","author":"Hofmann","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2024.02.005_bib20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jpsychires.2012.09.024","article-title":"Augmentation of exposure therapy with post-session administration of D-cycloserine","volume":"47","author":"Tart","year":"2013","journal-title":"J\u00a0Psychiatr Res"},{"issue":"10","key":"10.1016\/j.psc.2024.02.005_bib21","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jpsychires.2013.06.020","article-title":"D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions","volume":"47","author":"Smits","year":"2013","journal-title":"J\u00a0Psychiatr Res"},{"issue":"11","key":"10.1016\/j.psc.2024.02.005_bib22","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.biopsych.2012.12.009","article-title":"D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia","volume":"73","author":"Smits","year":"2013","journal-title":"Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.psc.2024.02.005_bib23","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.6777","article-title":"Dose timing of d-cycloserine to augment exposure therapy for social anxiety disorder: A randomized clinical trial","volume":"3","author":"Smits","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.psc.2024.02.005_bib24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/jamapsychiatry.2016.3955","article-title":"D-cycloserine augmentation of exposure-based cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders: A systematic review and meta-analysis of individual participant data","volume":"74","author":"Mataix-Cols","year":"2017","journal-title":"JAMA Psychiatr"},{"key":"10.1016\/j.psc.2024.02.005_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jad.2016.03.063","article-title":"Exercise as a treatment for depression: A meta-analysis","volume":"202","author":"Kvam","year":"2016","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.psc.2024.02.005_bib26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.psychres.2016.12.020","article-title":"An examination of the anxiolytic effects of exercise for people with anxiety and stress-related disorders: A meta-analysis","volume":"249","author":"Stubbs","year":"2017","journal-title":"Psychiatry Res"},{"issue":"8","key":"10.1016\/j.psc.2024.02.005_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11920-018-0923-x","article-title":"Moving to Beat Anxiety: Epidemiology and Therapeutic Issues with Physical Activity for Anxiety","volume":"20","author":"Kandola","year":"2018","journal-title":"Curr Psychiatry Rep"},{"issue":"4","key":"10.1016\/j.psc.2024.02.005_bib28","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/16506073.2015.1012740","article-title":"Exercise Augmentation of Exposure Therapy for PTSD: Rationale and Pilot Efficacy Data","volume":"44","author":"Powers","year":"2015","journal-title":"Cognit Behav Ther"},{"issue":"4","key":"10.1016\/j.psc.2024.02.005_bib29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.neubiorev.2013.02.003","article-title":"Exercising the worry away: How inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours","volume":"37","author":"Moylan","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"10.1016\/j.psc.2024.02.005_bib30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/16506073.2019.1641145","article-title":"Efficacy evaluation of exercise as an augmentation strategy to brief behavioral activation treatment for depression: a randomized pilot trial","volume":"49","author":"Szuhany","year":"2020","journal-title":"Cognit Behav Ther"},{"issue":"4","key":"10.1016\/j.psc.2024.02.005_bib31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/16506073.2015.1015163","article-title":"Running as Interoceptive Exposure for Decreasing Anxiety Sensitivity: Replication and Extension","volume":"44","author":"Sabourin","year":"2015","journal-title":"Cognit Behav Ther"},{"key":"10.1016\/j.psc.2024.02.005_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.799600","article-title":"Feasibility of an Exercise and CBT Intervention for Treatment of Depression: A Pilot Randomized Controlled Trial. Clinical Trial","volume":"13","author":"Meyer","year":"2022","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.psc.2024.02.005_bib33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jad.2017.05.012","article-title":"Effect of exercise augmentation of cognitive behavioural therapy for the treatment of suicidal ideation and depression","volume":"219","author":"Abdollahi","year":"2017","journal-title":"J\u00a0Affect Disord"},{"issue":"6","key":"10.1016\/j.psc.2024.02.005_bib34","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.janxdis.2007.09.010","article-title":"Promoting walking as an adjunct intervention to group cognitive behavioral therapy for anxiety disorders\u2014A pilot group randomized trial","volume":"22","author":"Merom","year":"2008","journal-title":"J\u00a0Anxiety Disord"},{"key":"10.1016\/j.psc.2024.02.005_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104867","article-title":"Boosting psychological change: Combining non-invasive brain stimulation with psychotherapy","volume":"142","author":"Tatti","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"10.1016\/j.psc.2024.02.005_bib36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41386-021-01094-3","article-title":"Noninvasive neuromodulation of the prefrontal cortex in mental health disorders","volume":"47","author":"Regenold","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.psc.2024.02.005_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20020930","article-title":"Effectiveness Evaluation of Repetitive Transcranial Magnetic Stimulation Therapy Combined with Mindfulness-Based Stress Reduction for People with Post-Stroke Depression: A Randomized Controlled Trial","volume":"20","author":"Duan","year":"2023","journal-title":"Int J Environ Res Public Health"},{"issue":"11","key":"10.1016\/j.psc.2024.02.005_bib38","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1176\/appi.ajp.2019.18101180","article-title":"Efficacy and Safety of Deep Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Prospective Multicenter Randomized Double-Blind Placebo-Controlled Trial","volume":"176","author":"Carmi","year":"2019","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2024.02.005_bib39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.brs.2012.07.008","article-title":"Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder--a pilot study","volume":"6","author":"Isserles","year":"2013","journal-title":"Brain Stimul"},{"issue":"10","key":"10.1016\/j.psc.2024.02.005_bib40","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.biopsych.2021.04.019","article-title":"Deep Transcranial Magnetic Stimulation Combined With Brief Exposure for Posttraumatic Stress Disorder: A Prospective Multisite Randomized Trial","volume":"90","author":"Isserles","year":"2021","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.psc.2024.02.005_bib41","first-page":"53","article-title":"Exposure Therapy and Simultaneous Repetitive Transcranial Magnetic Stimulation: A Controlled Pilot Trial for the Treatment of Posttraumatic Stress Disorder","volume":"35","author":"Fryml","year":"2019","journal-title":"J\u00a0ECT"},{"key":"10.1016\/j.psc.2024.02.005_bib42","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.nicl.2017.09.013","article-title":"Neurobiological and clinical effects of fNIRS-controlled rTMS in patients with panic disorder\/agoraphobia during cognitive-behavioural therapy","volume":"16","author":"Deppermann","year":"2017","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.psc.2024.02.005_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/542526","article-title":"Does rTMS alter neurocognitive functioning in patients with panic disorder\/agoraphobia? An fNIRS-based investigation of prefrontal activation during a cognitive task and its modulation via sham-controlled rTMS","volume":"2014","author":"Deppermann","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.psc.2024.02.005_bib44","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbr.2016.03.028","article-title":"Functional co-activation within the prefrontal cortex supports the maintenance of behavioural performance in fear-relevant situations before an iTBS modulated virtual reality challenge in participants with spider phobia","volume":"307","author":"Deppermann","year":"2016","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.psc.2024.02.005_bib45","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.biopsycho.2015.10.003","article-title":"Psychophysiological effects of an iTBS modulated virtual reality challenge including participants with spider phobia","volume":"112","author":"Notzon","year":"2015","journal-title":"Biol Psychol"},{"key":"10.1016\/j.psc.2024.02.005_bib46","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jad.2022.01.053","article-title":"Enhancing cognitive restructuring with concurrent fMRI-guided neurostimulation for emotional dysregulation-A randomized controlled trial","volume":"301","author":"Neacsiu","year":"2022","journal-title":"J\u00a0Affect Disord"},{"issue":"6","key":"10.1016\/j.psc.2024.02.005_bib47","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/jamapsychiatry.2022.0696","article-title":"Efficacy of Augmentation of Cognitive Behavioral Therapy With Transcranial Direct Current Stimulation for Depression: A Randomized Clinical Trial","volume":"79","author":"Aust","year":"2022","journal-title":"JAMA Psychiatr"},{"key":"10.1016\/j.psc.2024.02.005_bib48","first-page":"14","article-title":"Combining transcranial direct current stimulation with group cognitive behavioral therapy developed to treat rumination: a clinical pilot study. Original Research","author":"Horczak","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.psc.2024.02.005_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.563058","article-title":"Transcranial Direct Current Stimulation as an Add-on Treatment to Cognitive-Behavior Therapy in First Episode Drug-Na\u00efve Major Depression Patients: The ESAP Study Protocol. Study Protocol","author":"Carvalho","year":"2020","journal-title":"Front Psychiatry"},{"issue":"8","key":"10.1016\/j.psc.2024.02.005_bib50","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00406-017-0859-x","article-title":"PsychotherapyPlus: augmentation of cognitive behavioral therapy (CBT) with prefrontal transcranial direct current stimulation (tDCS) in major depressive disorder-study design and methodology of a multicenter double-blind randomized placebo-controlled trial","volume":"268","author":"Bajbouj","year":"2018","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"3","key":"10.1016\/j.psc.2024.02.005_bib51","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1037\/0735-7044.121.3.501","article-title":"The effect of yohimbine on the extinction of conditioned fear: a role for context","volume":"121","author":"Morris","year":"2007","journal-title":"Behav Neurosci"},{"issue":"11","key":"10.1016\/j.psc.2024.02.005_bib52","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.biopsych.2013.10.008","article-title":"Yohimbine Enhancement of Exposure Therapy for Social Anxiety Disorder: A Randomized Controlled Trial","volume":"75","author":"Smits","year":"2014","journal-title":"Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.psc.2024.02.005_bib53","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/16506073.2018.1432679","article-title":"Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl","volume":"47","author":"Tuerk","year":"2018","journal-title":"Cognit Behav Ther"},{"issue":"3","key":"10.1016\/j.psc.2024.02.005_bib54","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.janxdis.2009.01.001","article-title":"Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: A randomized placebo controlled trial of yohimbine augmentation","volume":"23","author":"Powers","year":"2009","journal-title":"J\u00a0Anxiety Disord"},{"key":"10.1016\/j.psc.2024.02.005_bib55","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.janxdis.2018.05.001","article-title":"Enhancement of exposure therapy in participants with specific phobia: A randomized controlled trial comparing yohimbine, propranolol and placebo","volume":"57","author":"Meyerbr\u00f6ker","year":"2018","journal-title":"J\u00a0Anxiety Disord"},{"issue":"1","key":"10.1016\/j.psc.2024.02.005_bib56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000329454","article-title":"Does Yohimbine Hydrochloride Facilitate Fear Extinction in Virtual Reality Treatment of Fear of Flying? A Randomized Placebo-Controlled Trial","volume":"81","author":"Meyerbroeker","year":"2011","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.psc.2024.02.005_bib57","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.neubiorev.2021.09.010","article-title":"Gonadal steroid hormones and emotional memory consolidation: A systematic review and meta-analysis","volume":"130","author":"Hsu","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"10.1016\/j.psc.2024.02.005_bib58","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.biopsych.2006.03.010","article-title":"Prefrontal mechanisms in extinction of conditioned fear","volume":"60","author":"Quirk","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"6911","key":"10.1016\/j.psc.2024.02.005_bib59","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nature01138","article-title":"Neurons in medial prefrontal cortex signal memory for fear extinction","volume":"420","author":"Milad","year":"2002","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.psc.2024.02.005_bib60","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.biopsych.2015.02.007","article-title":"Estrogen and Extinction of Fear Memories:Implications for Posttraumatic Stress Disorder Treatment","volume":"78","author":"Glover","year":"2015","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2024.02.005_bib61","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.biopsych.2012.09.018","article-title":"Blockade of estrogen by hormonal contraceptives impairs fear extinction in female rats and women","volume":"73","author":"Graham","year":"2013","journal-title":"Biol Psychiatry"},{"issue":"5719","key":"10.1016\/j.psc.2024.02.005_bib62","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.1105636","article-title":"Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala","volume":"308","author":"Huber","year":"2005","journal-title":"Science"},{"issue":"49","key":"10.1016\/j.psc.2024.02.005_bib63","doi-asserted-by":"crossref","first-page":"11489","DOI":"10.1523\/JNEUROSCI.3984-05.2005","article-title":"Oxytocin modulates neural circuitry for social cognition and fear in humans","volume":"25","author":"Kirsch","year":"2005","journal-title":"J\u00a0Neurosci"},{"issue":"6","key":"10.1016\/j.psc.2024.02.005_bib64","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.psyneuen.2009.01.005","article-title":"A\u00a0randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder","volume":"34","author":"Guastella","year":"2009","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"10.1016\/j.psc.2024.02.005_bib65","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/da.22362","article-title":"Intranasal oxytocin administration prior to exposure therapy for arachnophobia impedes treatment response","volume":"32","author":"Acheson","year":"2015","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.psc.2024.02.005_bib66","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jpsychires.2017.12.014","article-title":"Augmenting Prolonged Exposure therapy for PTSD with intranasal oxytocin: A randomized, placebo-controlled pilot trial","volume":"98","author":"Flanagan","year":"2018","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.psc.2024.02.005_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2020.106074","article-title":"Enhancing prolonged exposure therapy for PTSD among veterans with oxytocin: Design of a multisite randomized controlled trial","volume":"95","author":"Flanagan","year":"2020","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.psc.2024.02.005_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2023.107084","article-title":"COPE and oxytocin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in U.S. military veterans","volume":"126","author":"Back","year":"2023","journal-title":"Contemp Clin Trials"},{"issue":"2","key":"10.1016\/j.psc.2024.02.005_bib69","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.nlm.2006.08.009","article-title":"Methylene blue facilitates the extinction of fear in an animal model of susceptibility to learned helplessness","volume":"87","author":"Wrubel","year":"2007","journal-title":"Neurobiol Learn Mem"},{"issue":"10","key":"10.1016\/j.psc.2024.02.005_bib70","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1176\/appi.ajp.2014.13101407","article-title":"Effects of post-session administration of methylene blue on fear extinction and contextual memory in adults with claustrophobia","volume":"171","author":"Telch","year":"2014","journal-title":"Am J Psychiatry"},{"issue":"7","key":"10.1016\/j.psc.2024.02.005_bib71","doi-asserted-by":"crossref","first-page":"e782","DOI":"10.4088\/JCP.16m10936","article-title":"Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: A randomized controlled trial","volume":"78","author":"Zoellner","year":"2017","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"9","key":"10.1016\/j.psc.2024.02.005_bib72","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1038\/tp.2012.90","article-title":"Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1","volume":"2","author":"Heitland","year":"2012","journal-title":"Transl Psychiatry"},{"issue":"19","key":"10.1016\/j.psc.2024.02.005_bib73","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1111\/bph.13724","article-title":"Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders","volume":"174","author":"Lee","year":"2017","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.psc.2024.02.005_bib74","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00213-012-2955-y","article-title":"Cannabidiol enhances consolidation of explicit fear extinction in humans","volume":"226","author":"Das","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.psc.2024.02.005_bib75","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.euroneuro.2022.04.003","article-title":"Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial","volume":"59","author":"Kwee","year":"2022","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.psc.2024.02.005_bib76","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s40501-019-00172-0","article-title":"Augmenting the Treatment of PTSD with Ketamine\u2014a Review","volume":"6","author":"Duek","year":"2019","journal-title":"Current Treatment Options in Psychiatry"},{"issue":"8","key":"10.1016\/j.psc.2024.02.005_bib77","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1176\/appi.ajp.2017.16060637","article-title":"Randomized clinical trial of real-time fMRI amygdala neurofeedback for major depressive disorder: Effects on symptoms and autobiographical memory recall","volume":"174","author":"Young","year":"2017","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2024.02.005_bib78","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fnbeh.2015.00148","article-title":"fMRI neurofeedback facilitates anxiety regulation in females with spider phobia","volume":"9","author":"Zilverstand","year":"2015","journal-title":"Front Behav Neurosci"}],"container-title":["Psychiatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X24000066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X24000066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T01:37:25Z","timestamp":1715132245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0193953X24000066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0193953X24000066"],"URL":"https:\/\/doi.org\/10.1016\/j.psc.2024.02.005","relation":{},"ISSN":["0193-953X"],"issn-type":[{"value":"0193-953X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive-Behavioral Therapy Enhancement Strategies","name":"articletitle","label":"Article Title"},{"value":"Psychiatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psc.2024.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}